Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial

NCT05047198 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT05047198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05047198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 3
Overall status
Recruiting
Start date
December 6, 2022
Completion date
December 15, 2027
Enrollment
244 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia